Researchers from the University of Central Florida recently received a $400,000 grant from the Juvenile Diabetes Research Foundation, which they will use to create a tube that resists infection and encapsulation and is inserted under the skin for the delivery of insulin via a pump.
Featured
Industry News NOVARTIS CORPORATION: Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
Latest News
Industry News PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION: Applauds the Administration for Enacting Legislation to Ensure Patients Pay the Lowest Price for Prescription Drugs
Federal Issues
- U.S. DEPARTMENT OF HOMELAND SECURITY: DHS Statement on Protecting the Nation from Foreign Terrorist Entry to the United States
- PHARMACEUTICAL CARE MANAGEMENT CARE ASSOCIATION: Federal Circuit Court Unanimously Strikes Down Arkansas Mandate Restricting PBM Tools
- PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION: Congressional Budget Office Score of Medicare Point-of-Sale Rebates Undermines Drugmakers’ Signature Issue
- U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES: HHS Secretary Azar Praises FDA Approval of First Non-Opioid Treatment for Opioid Withdrawal
Industry News
CVS PHARMACY: Completes Rollout of Time Delay Safes in All of Its Maryland Pharmacies
- UCF researchers awarded $400,000 grant to create new insulin delivery tube
- PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION: Applauds the Administration for Enacting Legislation to Ensure Patients Pay the Lowest Price for Prescription Drugs
- ASTELLAS PHARMA US, INC: Astellas Statement on U.S. Drug Pricing
- UPPER-SMITH LABORATORIES, INC: UPSHER-SMITH EXPANDS PORTFOLIO WITH SIXTH PRODUCT LAUNCH IN 2018
Innovation
UCF researchers awarded $400,000 grant to create new insulin delivery tube
- Study shows effects of body lotions on capillary blood glucose
- ACADEMY OF MANAGED CARE PHARMACY: AMCP Partnership Forum to Develop Consensus Roadmap for Managing Total Cost of Care by Integrating Medical and Pharmacy Data
- TRIPLE-S MANAGEMENT CORPORATION: Selects Abarca as Pharmacy Benefits Manager for its Commercial and Medicare Businesses
- SANOFI US: New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma
Regulatory
- RITE AID: Applauds Passage of Legislation Helping Seniors Access Pharmacy Services to Prevent Opioid Abuse
- RITE AID: Establishes Policy for Addressing Chemicals of Consumer Concern
- U.S. FOOD AND DRUG ASSOCIATION (FDA): Announces voluntary recall of Montelukast tablets by Camber Pharmaceuticals due to incorrect drug in bottles
- BRISTOL-MYERS SQUIBB: European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for the Adjuvant Treatment of Adult Patients with Melanoma with Involvement of Lymph Nodes or Metastatic Disease Who Have Undergone Complete Resection
Alerts Sign-up